Specialized Nerve Stimulation Systems for High-Risk Environments

Publication ID: 24-11857788_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Nerve Stimulation Systems for High-Risk Environments,” Published Technical Disclosure No. 24-11857788_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857788_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,788.

Summary of the Inventive Concept

This inventive concept adapts the original coordinated trigeminal and vagal nerve stimulation method for reducing bleeding in specific, high-risk environments, such as high-altitude, disaster relief, extreme weather, and high-security settings, ensuring tailored solutions for unique operational needs.

Background and Problem Solved

The original patent disclosed a method and apparatus for reducing bleeding via coordinated trigeminal and vagal nerve stimulation. However, the original design may not be suitable for extreme environments, where additional considerations, such as low oxygen levels, waterproofing, and enhanced security, are crucial. This inventive concept addresses these limitations by introducing specialized variations and niche solutions for high-risk environments.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of systems and methods that adapt the original coordinated nerve stimulation approach to specific high-risk environments. For instance, a system for reducing bleeding in high-altitude environments features a portable apparatus adapted to operate at low oxygen levels and extreme temperatures. Another embodiment includes a waterproof apparatus with GPS tracking for treating bleeding in patients during natural disasters. Other variations include a wearable device with a sensor for monitoring blood coagulation levels in patients with bleeding disorders, an apparatus with enhanced security features for high-security facilities, and a ruggedized apparatus for treating bleeding in extreme weather environments.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original coordinated nerve stimulation method, tailored to specific high-risk environments. These adaptations, such as low-oxygen operation, waterproofing, and enhanced security, are non-obvious and provide a significant inventive step over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include, but are not limited to, systems for reducing bleeding in patients with specific medical conditions, such as hemophilia, or in patients undergoing surgery in remote or resource-constrained areas. Other variations could include adapting the apparatus for use in space exploration or in areas with limited access to medical resources.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including emergency response, disaster relief, high-security facilities, and extreme environment exploration. The market for these specialized nerve stimulation systems is expected to grow as the need for tailored solutions in high-risk environments increases.

Original Patent Information

Patent NumberUS 11,857,788
TitleMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
Assignee(s)THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH